| New K-absorbing compound prevents hyperkalemia with spironolactone. |
|
| Missed this one. Thanks to CKJ and Eberhard Ritz: From April in the European Heart Journal: Conclusion. RLY5016 prevented hyperkalaemia and was relatively well tolerated in patients with HF receiving standard therapy and spironolactone (25–50 mg/day) |